|
[1]SHI YQ, WANG X.Analysis the treatment of type 2 diabetes mellitus from the five internal organs[J].J Changchun Univ Chin Med, 2015, 31 (1) :68-70. (in Chinese) 史云秋, 王旭.从五脏论治2型糖尿病[J].长春中医药大学学报, 2015, 31 (1) :68-70.
|
|
[2]ASSELAH T, ESTRABAUD E, BIECHE I, et al.Hepatitis C:viral and host factors associated with non-response to pegylated interferon plus ribavirin[J].Liver Int, 2010, 30 (9) :1259-1269.
|
|
[3]KOSTERIN SA, BRATKOVA NF, KURSKII MD.Possible mechanism of the regulation of smooth muscle relaxation by calcium ions[J].Biofizika, 1987, 32 (2) :327-332.
|
|
[4]PERSICO M, IOLASCON A.Steatosis as a co-factor in chronic liver diseases[J].World J Gastroenterol, 2010, 16 (10) :1171-1176.
|
|
[5]MASARONE M, La MURA V, BRUNO S, et al.Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease[J].J Viral Hepatitis, 2007, 14 (10) :714-720.
|
|
[6]NEGRO F.Steatosis and insulin resistance in response to treatment of chronic hepatitis C[J].J Viral Hepatitis, 2012, 19 (Suppl 1) :42-47.
|
|
[7]BOCHUD PY, CAI T, OVERBECK K, et al.Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C[J].J Hepatol, 2009, 51 (4) :655-666.
|
|
[8]GARINIS GA, FRUCI B, MAZZA A, et al.Metformin versus dietary treatment in nonalcoholic hepatic steatosis:a randomized study[J].Int J Obesity, 2010, 34 (8) :1255-1264.
|
|
[9]ADINOLFI LE, RESTIVO L, MARRONE A.The predictive value of steatosis in hepatitis C virus infection[J].Expert Rev Gastroent, 2013, 7 (3) :205-213.
|
|
[10]SHEIKH MY, CHOI J, QADRI I, et al.Hepatitis C virus infection:molecular pathways to metabolic syndrome[J].Hepatology, 2008, 47 (6) :2127-2133.
|
|
[11]KONG WL, YANG YL, XU HQ, et al.Relationship between liver function and virological response in patients with chronic hepatic C during entiviral treatment[J].J JIlin Univ:Med Edit, 2016, 42 (1) :99-103. (in Chiese) 孔文丽, 杨以良, 徐洪芹, 等.慢性丙型肝炎患者抗病毒治疗中肝功能与病毒学应答的关系[J].吉林大学学报:医学版, 2016, 42 (1) :99-103.
|
|
[12]HAASTERT-TALINI K, GROTHE C.Comment to the paper:Acceleration of peripheral nerve regeneration using nerve conduits in combination with induced pluripotent stem cell technology and a basic fibroblast growth factor drug delivery system by M.Ikeda, T.Uemura, K.Takamatsu, M.Okada, K.Kazuki, Y.Tabata, Y.Ikada, H.Nakamura, J Biomed Mater Res A.2013 Jun 3 doi:10.1002/jbm.a.34816[J].J Biomed Mater Res A, 2014, 102 (4) :1219-1220.
|
|
[13]SARIN SK, KUMAR CK.Treatment of patients with genotype 3chronic hepatitis C-current and future therapies[J].Liver Int, 2012, 32 (Suppl 1) :141-145.
|
|
[14]ABENAVOLI L, MAZZA M, ALMASIO PL.The optimal dose of ribavirin for chronic hepatitis C:from literature evidence to clinical practice:the optimal dose of ribavirin for chronic hepatitis C[J].Hepat Mon, 2011, 11 (4) :240-246.
|
|
[15]SANYAL AJ.Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C[J].Liver Int, 2011, 31 (Suppl 1) :23-28.
|
|
[16]PERSICO M, CAPASSO M, PERSICO E, et al.Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis:insulin resistance and response to antiviral therapy[J].Hepatology, 2007, 46 (4) :1009-1015.
|
|
[17]SUN LJ, LI SC, ZHAO YH, et al.HCV core protein down-regulates AMP-activated protein kinase and the gucose metabolism disorders in hepatocytes[J].Chin Hepatol, 2013, 18 (3) :150-154. (in Chinese) 孙丽杰, 李树臣, 赵勇华, 等.丙型肝炎病毒核心蛋白下调AMP激活蛋白激酶对肝细胞脂类代谢的影响[J].肝脏, 2013, 18 (3) :150-154.
|
|
[18]PARVAIZ F, MANZOOR S, TARIQ H, et al.Hepatitis C virus infection:molecular pathways to insulin resistance[J].Virol J, 2011, 8:474.
|
|
[19]PARVAIZ F, MANZOOR S, IQBAL J, et al.Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis[J].World J Gastroenterol, 2015, 21 (43) :12361-12369.
|
|
[20]CHEN JZ, WANG Q, XU S.Hepatitis C virus core protein upregulates the transcription of PCK1 through FOXO1/PGC-1αpathway[J].Acta Microbiol Sin, 2012, 52 (1) :52-59. (in Chinese) 陈继征, 王倩, 徐松.丙型肝炎病毒核心蛋白通过FOXO1/PGC-1α途径上调磷酸烯醇式丙酮酸羧基酶的转录[J].微生物学报, 2012, 52 (1) :52-59.
|
|
[21]YU JW, SUN LJ, LIU W, et al.Changes in Th17 cells and natural killer T cells in peripheral blood of chronic hepatitis C patients with insulin resistance[J].Chin Hepatol, 2012, 17 (5) :319-321. (in Chinese) 于建武, 孙丽杰, 刘伟, 等.Th17细胞和自然杀伤性T细胞在胰岛素抵抗的慢性丙型肝炎患者外周血中的变化[J].肝脏, 2012, 17 (5) :319-321.
|
|
[22]WANG HL, LI XH, WANG GQ, et al.Results of antiviral treatment of chronic hepatitis C cases complicated with insulin resistance[J].China Trop Med, 2013, 13 (3) :390, 392. (in Chinese) 王会琳, 李新华, 王国强, 等.慢性丙型肝炎合并胰岛素抵抗的抗病毒治疗临床观察[J].中国热带医学, 2013, 13 (3) :390, 392.
|
|
[23]WEI L, LIU JK.Influence of lipid metabolism on the antiviral response in patients with chronic hepatitis C[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2012, 6 (5) :447-450. (in Chinese) 魏莉, 刘江奎.脂类代谢对慢性丙型肝炎抗病毒治疗疗效的影响[J/CD].中华实验和临床感染病杂志:电子版, 2012, 6 (5) :447-450.
|
|
[24]YU JW, SUN LJ, ZHAO YH, et al.The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance[J].Int J Infect Dis, 2012, 16 (6) :e436-e441.
|
|
[25]PREMJI R, ROOPNARINESINGH N, QAZI N, et al.New-onset diabetes mellitus with exposure to ledipasvir and sofosbuvir[J].J Invest Med High Impact Case Rep, 2015, 3 (4) :2324709615623300.
|
|
[26]POL S, VALLET-PICHARD A, COROUGE M.Treatment of hepatitis C virus genotype 3-infection[J].Liver Int, 2014, 34 (Suppl1) :18-23.
|
|
[27]LAWITZ E, MANGIA A, WYLES D, et al.Sofosbuvir for previously untreated chronic hepatitis C infection[J].New Engl J Med, 2013, 368 (20) :1878-1887.
|
|
[28]FLAMM SL.Commentary:sofosbuvir for treatment of hepatitis C virus genotype 2 or 3 infection in patients without treatment options[J].Gastroenterol Hepatol, 2013, 9 (10) :682-683.
|
|
[29]GRASSO A, MALFATTI F, TESTA R.Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C?[J].World J Gastroenterol, 2013, 19 (41) :6947-6956.
|
|
[30]KIRAN Z, ZUBERI BF, ANIS D, et al.Insulin resistance in non-diabetic patients of chronic Hepatitis C[J].Pak J Med Sci, 2013, 29 (1) :201-204.
|
|
[31]BOSE SK, RAY R.Hepatitis C virus infection and insulin resistance[J].World J Diabetes, 2014, 5 (1) :52-58.
|
DownLoad: